Steatohepatitis Stocks List

Recent Signals

Date Stock Signal Type
2019-08-23 AKRO Upper Bollinger Band Walk Strength
2019-08-23 AKRO NR7-2 Range Contraction
2019-08-23 AKRO NR7 Range Contraction
2019-08-23 GALT New 52 Week Low Weakness
2019-08-23 GALT New 52 Week Closing Low Bearish
2019-08-23 GALT Stochastic Reached Oversold Weakness
2019-08-23 GNFT Stochastic Reached Overbought Strength
2019-08-23 GNFT New Downtrend Bearish
2019-08-23 GNFT 20 DMA Support Bullish
2019-08-23 VKTX 20 DMA Resistance Bearish

Steatohepatitis is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. Mere deposition of fat in the liver is termed steatosis, and together these constitute fatty liver changes.There are two main types of fatty liver disease: alcohol-related fatty liver disease and non-alcoholic fatty liver disease (NAFLD). Risk factors for NAFLD include diabetes, obesity and metabolic syndrome. When inflammation is present it is referred to as alcoholic steatohepatitis and nonalcoholic steatohepatitis (NASH). Steatohepatitis of either cause may progress to cirrhosis, and NASH is now believed to be a frequent cause of unexplained cirrhosis (at least in Western societies). NASH is also associated with lysosomal acid lipase deficiency.The word is from steato-, meaning "fat" and hepatitis, meaning "inflammation of the liver".

More about Steatohepatitis